Phase 1 Obese Adults Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

HealthyOverweight and Obese Adults

Syntis Bio64 enrolled1 locationNCT07307274

Recruiting

Phase 1

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes

Alveus Therapeutics, Inc.180 enrolled1 locationNCT07399678